Identification of epidermal growth factor receptor-derived peptides immunogenic for HLA-A2(+) cancer patients

Epidermal growth factor receptor (EGFR) is one of the most appropriate target molecules for cancer therapy because of its relatively high expression in about one-third of all epithelial cancers in correlation with neoplasmic progression. With respect to EGFR-targeted therapies, antibodies and tyrosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shomura, H, Shichijo, S, Matsueda, S, Kawakami, T, Sato, Y, Todo, S, Itoh, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Molecular and Cellular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409701/
https://www.ncbi.nlm.nih.gov/pubmed/15083186
http://dx.doi.org/10.1038/sj.bjc.6601728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409701/
https://www.ncbi.nlm.nih.gov/pubmed/15083186
http://dx.doi.org/10.1038/sj.bjc.6601728

Ejemplares similares